Clinical, Immunophenotypic, and EBV Data of PCNSL Cases
| Patient . | Age/Sex . | Tumor Location . | CD20 . | CD79a . | CD3 . | CD45RO . | IgM . | IgG . | IgA . | κ . | λ . | EBER . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 61/F | Cerebral | + | + | − | − | NA | NA | NA | NA | NA | − |
| 2 | 71/M | Cerebella | + | + | − | − | + | ± | − | + | − | − |
| 3 | 59/F | Cerebral | + | + | − | − | + | − | − | + | − | − |
| 4 | 60/F | Cerebral | + | + | − | − | NA | NA | NA | NA | NA | − |
| 5 | 50/F | Cerebella | + | + | − | − | ± | − | − | + | − | − |
| Patient . | Age/Sex . | Tumor Location . | CD20 . | CD79a . | CD3 . | CD45RO . | IgM . | IgG . | IgA . | κ . | λ . | EBER . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 61/F | Cerebral | + | + | − | − | NA | NA | NA | NA | NA | − |
| 2 | 71/M | Cerebella | + | + | − | − | + | ± | − | + | − | − |
| 3 | 59/F | Cerebral | + | + | − | − | + | − | − | + | − | − |
| 4 | 60/F | Cerebral | + | + | − | − | NA | NA | NA | NA | NA | − |
| 5 | 50/F | Cerebella | + | + | − | − | ± | − | − | + | − | − |
Abbreviations: +, positive; −, negative; ±, a few immunopositive cells only; NA, not available.